Alcon Inc. (ALC)
SIX
Closed
Oct 8, 2026
Day's Range
51.7652 wk Range
47.80Overview - ALC - Alcon Inc.
Key Statistics
Valuation
Enterprise Value
24.38B
P/E (Trailing)
‪50.30‬
P/E (Forward)
‪14.76‬
PEG Ratio
‪-0.50‬
Price / Sales (TTM)
‪2.37‬
Price / Book
‪1.44‬
EV / EBITDA
‪12.32‬
Profitability
Gross Margin
‪59.33%‬
Profit Margin
‪5.92%‬
Operating Margin
‪14.63%‬
Return on Assets
‪2.79%‬
Return on Equity
‪2.94%‬
Ownership
Shares Outstanding
483.40M
Float
481.82M
Held by Insiders
‪0.19%‬
Held by Institutions
‪63.74%‬
Price stats
Beta
‪0.69‬
50-Day Avg
‪56.94‬
200-Day Avg
‪58.42‬
Dividends
Payout Ratio
‪27.03%‬
Frequency
Annual
Analyst Consensus
26 analysts
Average price target
‪CHF 74.32‬Market Cap - ALC - Alcon Inc.
Peers - ALC - Alcon Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on SIX.
Profile Summary - ALC - Alcon Inc.
About
Alcon Inc. is a global eye care company focused on products and technologies that support vision health across surgical and everyday care settings. Alcon Inc. develops, manufactures, and markets a broad portfolio for cataract surgery, vitreoretinal procedures, glaucoma care, refractive surgery, contact lenses, lens…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
